ATE462779T1 - Nukleinsäurefreie ghost zusammensetzungen - Google Patents

Nukleinsäurefreie ghost zusammensetzungen

Info

Publication number
ATE462779T1
ATE462779T1 AT02762349T AT02762349T ATE462779T1 AT E462779 T1 ATE462779 T1 AT E462779T1 AT 02762349 T AT02762349 T AT 02762349T AT 02762349 T AT02762349 T AT 02762349T AT E462779 T1 ATE462779 T1 AT E462779T1
Authority
AT
Austria
Prior art keywords
compositions
nucleic acid
free ghost
ghost
free
Prior art date
Application number
AT02762349T
Other languages
English (en)
Inventor
Werner Lubitz
Wolfgang Haidinger
Original Assignee
Lubitz Werner Prof Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lubitz Werner Prof Dr filed Critical Lubitz Werner Prof Dr
Application granted granted Critical
Publication of ATE462779T1 publication Critical patent/ATE462779T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/08—Reducing the nucleic acid content
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02762349T 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen ATE462779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30459501P 2001-07-11 2001-07-11
PCT/EP2002/007758 WO2003006630A2 (en) 2001-07-11 2002-07-11 Nucleic acid free ghost preparations

Publications (1)

Publication Number Publication Date
ATE462779T1 true ATE462779T1 (de) 2010-04-15

Family

ID=23177160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02762349T ATE462779T1 (de) 2001-07-11 2002-07-11 Nukleinsäurefreie ghost zusammensetzungen

Country Status (8)

Country Link
US (1) US7399476B2 (de)
EP (1) EP1404808B1 (de)
AT (1) ATE462779T1 (de)
AU (1) AU2002328340B2 (de)
CA (1) CA2453518C (de)
DE (1) DE60235809D1 (de)
NZ (1) NZ530780A (de)
WO (1) WO2003006630A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614471D0 (en) 2006-07-20 2006-08-30 Syngenta Ltd Herbicidal Compounds
ES2452471T3 (es) 2008-01-18 2014-04-01 Werner Lubitz Procedimiento de producción de fantasmas bacterianos (BG) utilizando beta-propiolactona (BPL) para la inactivación final
IN2012DN03418A (de) 2009-10-09 2015-10-23 Childrens Medical Center
ES2525205T3 (es) 2011-11-09 2014-12-18 Werner Lubitz Vacuna para su uso en inmunoterapia tumoral
EP3195878A1 (de) 2016-01-22 2017-07-26 Werner Lubitz Bakterielle ghosts zur behandlung von krebs
JP7376208B2 (ja) 2017-10-25 2023-11-08 アレーロ セラピューティクス ビーヴイ 抗原特異的製剤の投与による免疫疾患の治療
CN112410360A (zh) * 2021-01-18 2021-02-26 西南大学 一种鸡病原细菌菌影及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177083B1 (en) * 1990-07-26 2001-01-23 Evax Technologies Gmbh Process for the production of vaccines and their use
CA2173751A1 (en) * 1993-10-13 1995-04-20 Sýren Molin Recombinant staphylococcal nucleases and their use in limiting the survival of genetically engineered microorganisms

Also Published As

Publication number Publication date
US20040213810A1 (en) 2004-10-28
EP1404808A2 (de) 2004-04-07
NZ530780A (en) 2005-06-24
AU2002328340B2 (en) 2007-06-28
EP1404808B1 (de) 2010-03-31
US7399476B2 (en) 2008-07-15
DE60235809D1 (de) 2010-05-12
CA2453518A1 (en) 2003-01-23
WO2003006630A3 (en) 2003-10-23
WO2003006630A2 (en) 2003-01-23
CA2453518C (en) 2010-02-02

Similar Documents

Publication Publication Date Title
CY1119742T1 (el) Βιολογικα συστηματα μεταφορας πολλαπλου-συστατικου
IL233223A0 (en) Pharmaceutical preparations and diagnostic preparations containing corresponding nucleic acids and proteins known as p1g3282
ITRM980103A0 (it) Uso di batteri dotati di arginina deiminasi per introdurre apostosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
UA101301C2 (ru) ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ
WO2008057529A3 (en) Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
BR0010721A (pt) Composições de neisserias combinadas
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
NO20055838D0 (no) Aktive varianter av IL-18 bindende protein og medisinske anvendelser derav
DK1458760T3 (da) Indfangede bindingsproteiner som biosensorer
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
IL217317A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same and uses thereof
BR0207394A (pt) Proteìna de fusão para a secreção de uma proteìna de interesse no sobrenadante da cultura bacteriana
RS51737B (sr) Korišćenje inhibitora il-18
PL365246A1 (en) Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
TW200716226A (en) Compositions comprising actinidia and methods of use thereof
DE60235809D1 (de) Nukleinsäurefreie ghost zusammensetzungen
IL170080A (en) Nucleic acid and protein known as 158p1d7 and their pharmaceutical preparations
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
BRPI0407176A (pt) Cepas de bifidobacterium possuindo a capacidade de produzir glutamina
IT1270618B (it) Proteine ad attivita' antitumorale
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404808

Country of ref document: EP